Buserelin Completed Phase 1 Trials for Prostate Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00054106Hormone Therapy and OGX-011 Before Radical Prostatectomy in Treating Patients With Prostate Cancer